These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7778947)

  • 1. [Clinical immunology of hepato-splenic bilharziasis].
    Esterre P; Boisier P; Ravaolimalala VA; Roux J
    Arch Inst Pasteur Madagascar; 1994; 61(1):28-30. PubMed ID: 7778947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
    Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity and morbidity in human schistosomiasis mansoni.
    Butterworth AE; Curry AJ; Dunne DW; Fulford AJ; Kimani G; Kariuki HC; Klumpp R; Koech D; Mbugua G; Ouma JH
    Trop Geogr Med; 1994; 46(4 Spec No):197-208. PubMed ID: 7825222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium.
    Hagan P; Blumenthal UJ; Dunn D; Simpson AJ; Wilkins HA
    Nature; 1991 Jan; 349(6306):243-5. PubMed ID: 1898985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.
    Demeure CE; Rihet P; Abel L; Ouattara M; Bourgois A; Dessein AJ
    J Infect Dis; 1993 Oct; 168(4):1000-8. PubMed ID: 7690821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective.
    Dunne DW; Pearce EJ
    Microbes Infect; 1999 Jun; 1(7):553-60. PubMed ID: 10603572
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune profiles in hepatosplenic schistosomiasis mansoni after surgical treatments.
    Petroianu A; Antunes LJ
    J Int Med Res; 1998; 26(1):43-9. PubMed ID: 9513076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
    Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L
    Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulins in patients with schistosomiasis mansoni.
    Guimarães RX; Prícoli TI; Novo NF; de Paiva ER
    Arq Gastroenterol; 1979; 16(1):3-7. PubMed ID: 475612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some factors affecting prevalence of and immune responses to Schistosoma mansoni in schoolchildren in Gorgora, northwest Ethiopia.
    Degu G; Mengistu G; Jones J
    Ethiop Med J; 2002 Oct; 40(4):345-52. PubMed ID: 12596654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA antibodies to a protective antigen in human Schistosomiasis mansoni.
    Grzych JM; Grezel D; Xu CB; Neyrinck JL; Capron M; Ouma JH; Butterworth AE; Capron A
    J Immunol; 1993 Jan; 150(2):527-35. PubMed ID: 8419485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations.
    Remoué F; Rogerie F; Gallissot MC; Guyatt HL; Neyrinck JL; Diakkhate MM; Niang M; Butterworth AE; Auriault C; Capron A; Riveau G
    J Infect Dis; 2000 May; 181(5):1855-9. PubMed ID: 10823801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
    Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
    Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of immune complexes in ascitic fluid of hepatosplenic schistosomiasis.
    Khalil HM; Makled MK; el Sebai MM; el Naggar MK
    J Egypt Soc Parasitol; 1987 Dec; 17(2):699-705. PubMed ID: 3121767
    [No Abstract]   [Full Text] [Related]  

  • 15. Immuno-epidemiology of Ascaris lumbricoides infection in a high transmission community: antibody responses and their impact on current and future infection intensity.
    King EM; Kim HT; Dang NT; Michael E; Drake L; Needham C; Haque R; Bundy DA; Webster JP
    Parasite Immunol; 2005 Mar; 27(3):89-96. PubMed ID: 15882235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-dependent immunodepression in vivo in Schistosoma mansoni infected patients.
    Muniz-Junqueira MI; Tosta CE; Prata A
    Rev Soc Bras Med Trop; 1990; 23(1):27-31. PubMed ID: 2128545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological changes in splenectomized versus non splenectomized schistosomal hepatosplenic cases.
    Salem SA; Makled MK; Abel-Wahab MF; Sedky A; Montasser MF; Bishara SA; Ragheb MM; Younis TA
    J Egypt Soc Parasitol; 1987 Dec; 17(2):785-96. PubMed ID: 3121771
    [No Abstract]   [Full Text] [Related]  

  • 18. Discriminating acute from chronic human schistosomiasis mansoni.
    Beck L; Van-Lüme DS; Souza JR; Domingues AL; Favre T; Abath FG; Montenegro SM
    Acta Trop; 2008; 108(2-3):229-33. PubMed ID: 18851939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor in hepatosplenic schistosomiasis.
    Zwingenberger K; Irschick E; Vergetti Siqueira JG; Correia Dacal AR; Feldmeier H
    Scand J Immunol; 1990 Feb; 31(2):205-11. PubMed ID: 2106723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile rhesus monkeys have lower type 2 cytokine responses than adults after primary infection with Schistosoma mansoni.
    Fallon PG; Gibbons J; Vervenne RA; Richardson EJ; Fulford AJ; Kiarie S; Sturrock RF; Coulson PS; Deelder AM; Langermans JA; Thomas AW; Dunne DW
    J Infect Dis; 2003 Mar; 187(6):939-45. PubMed ID: 12660940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.